By Fineline Cube 
The Sanofi Cathy Capital Pharmaceutical Innovation Fund, a joint venture between French pharmaceutical giant Sanofi (EPA: SAN, NASDAQ: SNY) and global investment firm Cathay Capital, was officially launched in Shanghai this week. With a total capital of RMB 2 billion (USD 274 million), the fund aims to invest in innovative clinical-stage pipelines and industry opportunities in China, accelerating the localization of novel drugs.
Fund Details
The fund will leverage Sanofi’s global pharmaceutical expertise and Cathay Capital’s investment insights to foster deep cooperation between Chinese and foreign pharmaceutical companies. It will focus on promoting technology, product, and market integration, offering diversified innovative solutions to China’s pharmaceutical sector.-Fineline Info & Tech